U.S. President Donald Trump delivers remarks on supporting the passage of the U.S.-Mexico-Canada (USMCA) trade deal during a visit to Derco Aerospace Inc., a Lockheed Martin subsidiary, in Milwaukee, Wisconsin, U.S., July 12, 2019. REUTERS/Carlos Barria?
WASHINGTON (Reuters) - Democrats see U.S. President Donald Trump becoming increasingly vulnerable to criticism about healthcare costs after the administration's decision to scrap a proposal to lower drug prices, and 2020 White House candidates are rushing to seize the spotlight on the issue.
The debate over the future of the American healthcare system has become a focal point of the Democratic presidential nominating contest. As Trump has failed to make strides to remedy the problem, Democrats are becoming more vocal.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
